Page 955 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 955

CHAPTER 53  Clinical Pharmacology of the Antihelminthic Drugs        941


                    more susceptible to destruction by host defense mechanisms. The   pain. Leukocytosis is common and eosinophilia may increase with
                    mode of action against adult worms is unknown.       treatment. Proteinuria also may occur. Symptoms are most likely
                                                                         to  occur  in  patients  with  heavy  loads  of  microfilariae.  Retinal
                    Clinical Uses                                        hemorrhages and, rarely, encephalopathy have been described.
                                                                         Local reactions may occur in the vicinity of dying adult or imma-
                    The drug should be taken after meals.                ture worms. These include lymphangitis with localized swellings in
                    1. Wuchereria bancrofti, Brugia malayi, Brugia timori, and   W bancrofti and B malayi, small wheals in the skin in L loa, and flat
                    Loa loa—Diethylcarbamazine is the drug of choice for treatment   papules in M streptocerca infections. Patients with attacks of lym-
                    of infections with these parasites because of its efficacy and lack of   phangitis due to W bancrofti or B malayi should be treated during
                    serious toxicity. Microfilariae of all species are rapidly killed; adult   a quiescent period between attacks. Caution is advised when using
                    parasites are killed more slowly, often requiring several courses of   diethylcarbamazine in patients with hypertension or renal disease.
                    treatment. The drug is highly effective against adult L loa. The extent
                    to which W bancrofti and B malayi adults are killed is not known,   DOXYCYCLINE
                    but after appropriate therapy microfilariae do not reappear in the
                    majority  of  patients.  Lymphatic  filariasis  is  treated  with  2  mg/kg   This tetracycline antibiotic is described in  more detail in
                    three times a day for 12 days, and loiasis is treated with the same   Chapter 44. Doxycycline has recently been shown to have
                    regimen for 2–3 weeks. Antihistamines may be given for the first few   significant macrofilaricidal activity against W bancrofti, suggesting
                    days of therapy to limit allergic reactions, and corticosteroids should   better activity than any other available drug against adult worms.
                    be started and doses of diethylcarbamazine lowered or interrupted   Activity is also seen against onchocerciasis. Doxycycline acts indi-
                    if severe reactions occur. Cures may require several courses of treat-  rectly, by killing Wolbachia, an intracellular bacterial symbiont of
                    ment. For patients with high L loa worm burdens (more than 2500   filarial parasites. It may prove to be an important drug for filariasis
                    circulating parasites/mL), strategies to decrease risks of severe toxic-  and onchocerciasis, both for treatment of active disease and in
                    ity include (a) apheresis, if available, to remove microfilariae before   mass chemotherapy campaigns.
                    treatment with diethylcarbamazine, or (b) therapy with albendazole,
                    which is slower acting and better tolerated, followed by therapy with
                    diethylcarbamazine  or  ivermectin.  Diethylcarbamazine  may  also   IVERMECTIN
                    be used for chemoprophylaxis against filarial infections (300 mg
                    weekly or 300 mg on 3 successive days each month for loiasis; 50 mg   Ivermectin is the drug of choice in strongyloidiasis and onchocer-
                    monthly for bancroftian and Malayan filariasis).     ciasis. It is also an alternative drug for a number of other helmin-
                                                                         thic infections (Table 53–1).
                    2. Other uses—For  tropical  eosinophilia,  diethylcarbamazine is
                    given orally at a dosage of 2 mg/kg three times daily for 2–3 weeks.   Basic Pharmacology
                    Diethylcarbamazine is effective in Mansonella streptocerca infections,   Ivermectin, a semisynthetic macrocyclic lactone derived from the
                    since it kills both adults and microfilariae. Limited information   soil actinomycete Streptomyces avermitilis, is a mixture of avermec-
                    suggests that the drug is not effective, however, against adult   tin B  and B . Ivermectin is available only for oral administration
                                                                             1a
                                                                                   1b
                    Mansonella ozzardi or Mansonella perstans and that it has limited   in humans.  The drug is rapidly absorbed, reaching maximum
                    activity against microfilariae of these parasites. An important appli-  plasma concentrations 4 hours after a 12-mg dose. Ivermectin has
                    cation of diethylcarbamazine has been mass treatment to reduce the   a wide tissue distribution and a volume of distribution of about
                    prevalence of W bancrofti infection, generally in combination with   50 L. Its half-life is about 16 hours. Excretion of the drug and its
                    ivermectin or albendazole. This strategy has led to excellent progress   metabolites is almost exclusively in the feces.
                    in disease control in a number of countries.
                                                                           Ivermectin appears to paralyze nematodes and arthropods by
                                                                         intensifying γ-aminobutyric acid (GABA)-mediated transmission of
                    Adverse Reactions, Contraindications,                signals in peripheral nerves. In onchocerciasis, ivermectin is micro-
                    & Cautions                                           filaricidal. It does not effectively kill adult worms but blocks the
                                                                         release of microfilariae for some months after therapy. After a single
                    Reactions to diethylcarbamazine, which are generally mild and
                    transient, include headache, malaise, anorexia, weakness, nausea,   standard dose, microfilariae in the skin diminish rapidly within
                    vomiting, and dizziness. Adverse effects also occur as a result of   2–3  days,  remain  low  for  months,  and  then  gradually  increase;
                    the release of proteins from dying microfilariae or adult worms.   microfilariae in the anterior chamber of the eye decrease slowly over
                    Reactions  can  be  particularly  severe  with  onchocerciasis,  but   months, eventually clear, and then gradually return. With repeated
                    diethylcarbamazine is no longer commonly used for this infection   doses of ivermectin, the drug appears to have a low-level macrofilar-
                    because ivermectin is equally efficacious and less toxic. Reactions   icidal action and to permanently reduce microfilarial production.
                    to dying microfilariae are usually mild in  W bancrofti, more   Clinical Uses
                    intense in B malayi, and occasionally severe in L loa infections.
                    Reactions include fever, malaise, papular rash, headache, gas-  1. Onchocerciasis—Treatment  is  with  a  single  oral  dose  of
                    trointestinal  symptoms,  cough,  chest pain,  and  muscle  or  joint   ivermectin, 150 mcg/kg, with water on an empty stomach.
   950   951   952   953   954   955   956   957   958   959   960